A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Desoxycorticosterone pivalate
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Protirelin
The therapeutic efficacy of Protirelin can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Potassium perchlorate
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Thyroid, porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Teriparatide
The therapeutic efficacy of Teriparatide can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Parathyroid hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Tiratricol
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Dovitinib.
Desoxycorticosterone pivalate
Prucalopride
The metabolism of Prucalopride can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Revefenacin
Dovitinib may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Desoxycorticosterone pivalate
Sincalide
The excretion of Sincalide can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Letermovir
The metabolism of Letermovir can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Dexibuprofen
The metabolism of Dexibuprofen can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Gemfibrozil
The metabolism of Gemfibrozil can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Baloxavir marboxil
The metabolism of Baloxavir marboxil can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Candesartan
The metabolism of Candesartan can be decreased when combined with Dovitinib.
Desoxycorticosterone pivalate
Lorlatinib
The metabolism of Lorlatinib can be decreased when combined with Dovitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3